News
Cannabidiol (CBD) and cannabigerol (CBG) are increasingly studied for their therapeutic applications in neurological and vision-related conditions. While lower doses (20–300 mg/day) are effective for mild to moderate symptoms, emerging research suggests high doses (600–1000 mg/day) may provide amplified benefits for certain conditions. Let’s dive into the science supporting these high-dose treatments and their specific applications.
Continue reading
